Mercer Global Advisors
CLB icon

Mercer Global Advisors’s Core Laboratories CLB Stock Holding History

Mercer Global Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
+10,672
New +$152K ﹤0.01% 3379
2025
Q4 		– Sell
-10,699
Closed -$132K – 2867
2025
Q3 		$132K Buy
+10,699
New +$125K ﹤0.01% 2476

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mercer Global Advisors's CLB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Core Laboratories (CLB) in Q2 2026: 10,672 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #3379 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in CLB as recently as Q3 2025.

Mercer Global Advisors first reported a position in CLB in Q3 2025 and has held it in 2 quarters since. The position peaked at $132K in Q3 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Mercer Global Advisors held 10,672 shares of Core Laboratories worth $124K as of Q2 2026.
  • Core Laboratories was a new Mercer Global Advisors position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3379 holding.
  • Mercer Global Advisors first reported a position in Core Laboratories in Q3 2025 and has held it in 2 quarters since.
  • Mercer Global Advisors's Core Laboratories position peaked at $132K in Q3 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.